GO:0062124 4-hydroxybutyrate receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062124 (4-hydroxybutyrate receptor activity) is a molecular function defined as combining with 4-hydroxybutyrate to initiate a change in cell activity.
• The term is synonymous with gamma-hydroxybutyrate receptor activity, reflecting the common abbreviation GHB.
• 4-hydroxybutyrate (GHB) acts as a neuromodulator and therapeutic agent, with receptor activity linked to sedation, sleep regulation, and narcolepsy treatment.
• GHB receptor function has been studied via modulation of nitric oxide synthase activity in rat frontal cortex, indicating downstream signaling.
• GHB promotes oscillatory activity in thalamocortical neurons through a tonic GABAB receptor-mediated hyperpolarization, highlighting interplay with GABAergic systems.
• GHB intoxication and therapeutic use (sodium oxybate) underscore the clinical importance of understanding its receptor activity.
Description
4-hydroxybutyrate receptor activity (GO:0062124) is a molecular function that mediates cellular responses to 4-hydroxybutyrate (GHB), a short-chain fatty acid derivative with neuromodulatory properties. This activity is defined as combining with 4-hydroxybutyrate to initiate a change in cell activity, and it is synonymous with gamma-hydroxybutyrate receptor activity. The receptor is of significant interest because GHB is both an endogenous metabolite and a therapeutic agent used in narcolepsy and other conditions. Understanding this receptor activity is crucial for elucidating mechanisms of sleep regulation, anesthesia, and drug abuse. Research has shown that GHB receptor function can be studied through modulation of nitric oxide synthase activity in rat frontal cortex, providing a biochemical readout. Additionally, GHB promotes oscillatory activity in thalamocortical neurons via a tonic GABAB receptor-mediated hyperpolarization, suggesting crosstalk between GHB and GABAergic systems. These findings highlight the receptor's role in neuronal excitability and network dynamics. Given the clinical relevance of GHB in treating narcolepsy and its potential for misuse, precise characterization of its receptor activity is essential for developing targeted therapies and understanding adverse effects.
4-hydroxybutyrate receptor activity At A Glance
| GO ID | GO:0062124 |
|---|---|
| GO term | 4-hydroxybutyrate receptor activity |
| Ontology | molecular_function |
| Synonym | gamma-hydroxybutyrate receptor activity |
| Major function | Binding of 4-hydroxybutyrate to initiate a change in cell activity |
| Definition source | QuickGO |
| Related disease | Narcolepsy, GHB intoxication |
| Therapeutic agent | Sodium oxybate |
What Is GO:0062124?
According to the Gene Ontology, 4-hydroxybutyrate receptor activity (GO:0062124) is a molecular function defined as combining with 4-hydroxybutyrate to initiate a change in cell activity. This activity is synonymous with gamma-hydroxybutyrate receptor activity. It represents the initial step in a signaling cascade triggered by the binding of 4-hydroxybutyrate to its receptor, leading to downstream cellular responses.
Why Is 4-hydroxybutyrate receptor activity Important in Cell Biology?
4-hydroxybutyrate receptor activity is important because it mediates the effects of GHB, a compound with dual roles as an endogenous neuromodulator and a therapeutic drug for narcolepsy. Dysregulation of this activity is associated with GHB intoxication, which can cause severe respiratory depression and coma. Moreover, the receptor's interplay with GABAergic systems influences sleep architecture and neuronal oscillations, making it a target for understanding sleep disorders and anesthetic mechanisms. Research into this receptor activity also sheds light on drug abuse and potential therapeutic applications.
• Mediates the therapeutic effects of sodium oxybate in narcolepsy, improving sleep and reducing cataplexy.
• Central to the pathophysiology of GHB intoxication, which can lead to respiratory depression and coma.
• Involved in modulation of nitric oxide synthase activity, linking to redox signaling.
• Promotes thalamocortical oscillations, affecting sleep and arousal states.
• Interacts with GABAB receptor-mediated hyperpolarization, influencing neuronal excitability.
• Potential target for treating sleep disorders and anesthesia.
• Relevant to drug abuse and withdrawal syndromes.
• May play a role in medication-induced sleepwalking.
• Provides a model for studying orphan G-protein coupled receptors.
• Important for understanding endogenous GHB physiology and metabolism.
Molecular Mechanism of 4-hydroxybutyrate receptor activity
Ligand Binding and Receptor Activation
In simple terms: GHB binds to its receptor, like a key fitting a lock, to start a signal inside the cell.
4-hydroxybutyrate (GHB) binds to its specific receptor, initiating a conformational change that activates intracellular signaling pathways. This binding is the defining event of GO:0062124. The receptor is thought to be a G-protein coupled receptor, although its exact identity remains debated. Activation leads to downstream effects such as modulation of ion channels and second messengers.
Downstream Signaling: Nitric Oxide Synthase Modulation
In simple terms: After GHB binds, it can change the activity of an enzyme that makes nitric oxide, affecting cell signaling.
GHB receptor function has been studied by measuring its modulation of nitric oxide synthase (NOS) activity in rat frontal cortex punches. This suggests that NOS is a downstream effector of GHB receptor activation, linking the receptor to nitric oxide signaling, which can influence neuronal function and blood flow.
Interaction with GABAergic Systems
In simple terms: GHB can also affect neurons by interacting with GABA receptors, leading to inhibition.
GHB promotes oscillatory activity in rat and cat thalamocortical neurons by inducing a tonic GABAB receptor-mediated hyperpolarization. This indicates that GHB's effects are not solely through its own receptor but involve crosstalk with GABAergic pathways, potentially contributing to its sedative and anesthetic properties.
Physiological Outcomes: Sleep and Neuronal Oscillations
In simple terms: The receptor's activity influences sleep patterns and brain wave rhythms.
Activation of 4-hydroxybutyrate receptor activity is linked to modulation of sleep architecture, as evidenced by the therapeutic use of sodium oxybate in narcolepsy. GHB promotes thalamocortical oscillations, which are important for sleep spindles and arousal. These effects underscore the receptor's role in regulating sleep and consciousness.
Regulation and Desensitization
In simple terms: The receptor's response can be tuned up or down, and repeated stimulation may reduce its sensitivity.
While specific regulatory mechanisms for GO:0062124 are not fully defined, general principles of receptor regulation likely apply, including desensitization and internalization. Chronic GHB use can lead to tolerance and dependence, suggesting adaptive changes in receptor signaling. Further research is needed to elucidate these regulatory pathways.
Key Genes Involved in GO:0062124 4-hydroxybutyrate receptor activity
The following genes and proteins are implicated in 4-hydroxybutyrate receptor activity and its downstream signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GABBR1 | GABAB receptor subunit 1 | Mediates GHB-induced hyperpolarization in thalamocortical neurons |
| GABBR2 | GABAB receptor subunit 2 | Forms functional GABAB receptors with GABBR1, involved in GHB effects |
| NOS1 | Neuronal nitric oxide synthase | Modulated by GHB receptor activity in rat frontal cortex |
| NOS2 | Inducible nitric oxide synthase | Potential downstream effector of GHB signaling |
| NOS3 | Endothelial nitric oxide synthase | May be affected by GHB-induced nitric oxide changes |
| GHB receptor (unknown) | Putative GHB receptor | Mediates specific GHB binding and signaling |
| SLC6A1 | GABA transporter 1 | May influence extracellular GABA and GHB crosstalk |
| GAD1 | Glutamate decarboxylase 1 | Synthesizes GABA, potentially interacting with GHB systems |
| GAD2 | Glutamate decarboxylase 2 | Synthesizes GABA, potentially interacting with GHB systems |
| GRIN1 | NMDA receptor subunit 1 | May be indirectly affected by GHB-induced oscillations |
| GRIN2A | NMDA receptor subunit 2A | May be indirectly affected by GHB-induced oscillations |
| KCNQ2 | Potassium channel subunit | Involved in neuronal excitability, potentially modulated by GHB |
| KCNQ3 | Potassium channel subunit | Involved in neuronal excitability, potentially modulated by GHB |
| SCN1A | Sodium channel subunit | May influence neuronal oscillations affected by GHB |
| SCN2A | Sodium channel subunit | May influence neuronal oscillations affected by GHB |
| CACNA1B | Calcium channel subunit | May mediate calcium-dependent GHB effects |
| ADCY1 | Adenylyl cyclase 1 | Potential downstream effector of GHB receptor signaling |
How Is 4-hydroxybutyrate receptor activity Regulated?
The regulation of 4-hydroxybutyrate receptor activity is not fully characterized. However, chronic GHB administration can lead to tolerance and dependence, suggesting receptor desensitization or downregulation. Additionally, the interplay with GABAB receptors may modulate GHB effects, as GABAB antagonists can block some GHB-induced responses. Further research is needed to identify specific regulatory proteins and pathways.
4-hydroxybutyrate receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GABBR1 | Narcolepsy, sleep disorders | Knockout mouse, point mutation |
| GABBR2 | Narcolepsy, sleep disorders | Knockout mouse, point mutation |
| NOS1 | GHB intoxication, neurodegeneration | Knockout mouse, overexpression |
| GHB receptor (unknown) | GHB intoxication, narcolepsy | Knock-in, knockout |
| SLC6A1 | Epilepsy, sleep disorders | Knockout, point mutation |
Narcolepsy
Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness and cataplexy. Sodium oxybate, a form of GHB, is an effective treatment for narcolepsy, acting through 4-hydroxybutyrate receptor activity to improve sleep architecture and reduce cataplexy. The receptor's role in promoting slow-wave sleep and modulating thalamocortical oscillations is central to its therapeutic effect.
GHB Intoxication
GHB intoxication, often from recreational use or overdose, can cause severe respiratory depression, coma, and death. The effects are mediated by 4-hydroxybutyrate receptor activity, particularly in the central nervous system. Understanding the receptor's function is critical for developing antidotes and managing intoxication.
Medication-Induced Sleepwalking
Medications that modulate sleep, including sodium oxybate, have been associated with sleepwalking and other parasomnias. A systematic review found that medication-induced sleepwalking can occur with various drugs, and GHB's effects on sleep architecture may contribute to this phenomenon. The role of 4-hydroxybutyrate receptor activity in sleep regulation suggests a potential link.
From 4-hydroxybutyrate receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GABBR1 mediate GHB-induced hyperpolarization? | GABBR1 knockout mouse |
| What is the role of NOS1 in GHB receptor signaling? | NOS1 knockout rat |
| Can a point mutation in GABBR2 alter GHB sensitivity? | GABBR2 point-mutation knock-in mouse |
| How does overexpression of the putative GHB receptor affect sleep? | Transgenic overexpression mouse |
| What are the downstream targets of GHB receptor activation? | Tagged knock-in for proteomics |
| Does chronic GHB treatment lead to receptor desensitization? | Repeated-dose knockout and wild-type models |
How to Study the 4-hydroxybutyrate receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion channel currents, membrane potential | Measuring GHB effects on neuronal excitability |
| Nitric oxide synthase assay | NOS enzyme activity | Assessing GHB receptor signaling in brain tissue |
| Polysomnography | Sleep stages and architecture | Evaluating sodium oxybate effects in narcolepsy |
| Radioligand binding | Receptor binding affinity | Characterizing GHB receptor pharmacology |
| Immunohistochemistry | Protein localization | Mapping GHB receptor expression in brain |
| Microdialysis | Neurotransmitter levels | Measuring GABA and GHB in vivo |
| Behavioral tests | Sleep/wake behavior | Assessing GHB-induced sedation |
| Genetic knockout | Gene function | Determining role of candidate genes |
Electrophysiology
Electrophysiological recordings, such as patch-clamp and extracellular recordings, are used to measure the effects of GHB on neuronal excitability and oscillatory activity. For example, GHB promotes oscillatory activity in thalamocortical neurons, which can be recorded in brain slices.
Biochemical Assays for Nitric Oxide Synthase
The modulation of nitric oxide synthase activity by GHB receptor activation can be measured using biochemical assays that quantify nitric oxide production or NOS enzyme activity in tissue punches, as demonstrated in rat frontal cortex.
Behavioral Sleep Studies
Sleep architecture and behavioral responses to GHB can be assessed using polysomnography and sleep scoring in animal models or human clinical studies, particularly relevant for narcolepsy research.
Pharmacological Interventions
Using agonists and antagonists of GHB and GABA receptors, researchers can dissect the specific contributions of 4-hydroxybutyrate receptor activity versus GABAB receptor-mediated effects.
How CRISPR Can Be Used to Study GO:0062124 4-hydroxybutyrate receptor activity
Knockout
CRISPR knockout of genes encoding putative GHB receptor components or downstream effectors (e.g., GABBR1, NOS1) can elucidate their role in 4-hydroxybutyrate receptor activity. For instance, knocking out GABBR1 would test its necessity for GHB-induced hyperpolarization.
Point Mutation
Introducing point mutations in candidate receptor genes can help identify key residues involved in ligand binding or signaling. For example, mutating specific amino acids in GABBR2 might alter GHB sensitivity, providing insights into receptor function.
Knock-in
Knock-in of tagged versions of the receptor or its subunits (e.g., HA-tagged GABBR1) allows for pull-down and proteomic analysis to identify interacting proteins and downstream signaling complexes.
Overexpression
Overexpression of the putative GHB receptor or its subunits in cell lines or animal models can enhance signaling and facilitate biochemical studies. For example, overexpressing GABBR1 and GABBR2 in HEK cells can create a functional GHB-responsive receptor for drug screening.
How EDITGENE Supports 4-hydroxybutyrate receptor activity Research
Researchers studying 4-hydroxybutyrate receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, sleep regulation, or drug responses. EDITGENE provides comprehensive CRISPR gene editing services to create precisely tailored cell and animal models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for 4-hydroxybutyrate receptor activity research.
Frequently Asked Questions About 4-hydroxybutyrate receptor activity
What is 4-hydroxybutyrate receptor activity?
4-hydroxybutyrate receptor activity (GO:0062124) is a molecular function where the receptor binds 4-hydroxybutyrate (GHB) to initiate a change in cell activity.
What genes are involved in 4-hydroxybutyrate receptor activity?
Genes such as GABBR1, GABBR2, and NOS1 have been implicated in mediating or modulating the effects of GHB receptor activation.
What is the synonym for 4-hydroxybutyrate receptor activity?
The synonym is gamma-hydroxybutyrate receptor activity, reflecting the common abbreviation GHB.
How is 4-hydroxybutyrate receptor activity studied?
It is studied using electrophysiology, nitric oxide synthase assays, radioligand binding, and behavioral sleep studies in animal models.
What diseases are associated with 4-hydroxybutyrate receptor activity?
Narcolepsy, GHB intoxication, and medication-induced sleepwalking are associated with this receptor activity.
What is the role of 4-hydroxybutyrate receptor activity in narcolepsy?
Sodium oxybate, a GHB analog, acts through this receptor to improve sleep architecture and reduce cataplexy in narcolepsy patients.
How does GHB affect thalamocortical neurons?
GHB promotes oscillatory activity in thalamocortical neurons by inducing a tonic GABAB receptor-mediated hyperpolarization.
Can CRISPR be used to study 4-hydroxybutyrate receptor activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of genes involved in this receptor activity.
What is the GO ID for 4-hydroxybutyrate receptor activity?
The GO ID is GO:0062124.
What is the definition of 4-hydroxybutyrate receptor activity according to QuickGO?
Combining with 4-hydroxybutyrate to initiate a change in cell activity.
Conclusion
4-hydroxybutyrate receptor activity (GO:0062124) is a critical molecular function mediating the diverse effects of GHB, from sleep regulation to anesthesia and drug abuse. Understanding its mechanism and regulation is essential for developing targeted therapies for narcolepsy and managing GHB intoxication. Continued research using advanced CRISPR models and biochemical assays will further elucidate this receptor's role in health and disease.
References
- 2. Dufayet L et al.. 2023. Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review.. Regul Toxicol Pharmacol 142:105435 PMID: 37343712
- 3. Cash CD et al.. 1999. Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches.. Biochem Pharmacol 58(11):1815-9 PMID: 10571257
- 4. Williams SR et al.. 1995. Gamma-hydroxybutyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB, receptor-mediated hyperpolarization.. Neuroscience 66(1):133-41 PMID: 7637863
- 5. Mamelak M. 2022. Sleep, Narcolepsy, and Sodium Oxybate.. Curr Neuropharmacol 20(2):272-291 PMID: 33827411
- 6. Barateau L et al.. 2019. Recent advances in treatment for narcolepsy.. Ther Adv Neurol Disord 12:1756286419875622 PMID: 31632459
- 7. Tunnicliff G et al.. 2002. Gamma-Hydroxybutyrate (orphan medical).. Curr Opin Investig Drugs 3(2):278-83 PMID: 12020060
- 8. Stallman HM et al.. 2018. Medication induced sleepwalking: A systematic review.. Sleep Med Rev 37:105-113 PMID: 28363449
